Market Tracker

09/28 9:45am ET
171.11
BATS BZX Real-Time Price
As of 9:45am ET
 -0.52 / -0.30%
Today’s Change
130.09
Today|||52-Week Range
176.85
+5.41%
Year-to-Date
Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data
9:32am / Zacks.com - Paid Partner Content
Amgen (AMGN) Stock Slides, RBC: Clarion Trial May Have Failed Due to Design
Sep 27 / TheStreet.com - Paid Partner Content
Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III
7:54am / Zacks.com - Paid Partner Content
Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.
Sep 27 / Zacks.com - Paid Partner Content
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter
Sep 27 / GuruFocus News - Paid Partner Content
Stocks Climb in Post-Debate Relief Rally, Crude Oil Sinks
Sep 27 / TheStreet.com - Paid Partner Content
Here's Why Ligand Pharmaceuticals Inc Is Plunging Today
Sep 27 / MotleyFool.com - Paid Partner Content
Biosimilars in Limelight on FDA Approval of Amgen Drug
Sep 27 / Zacks.com - Paid Partner Content
Stocks Hold at Highs After Clinton-Trump Debate, Oil Tumbles
Sep 27 / TheStreet.com - Paid Partner Content
Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients
Sep 27 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close171.63
Today’s open171.73
Day’s range170.90 - 171.73
Volume4,681
Average volume (3 months)2,816,038
Market cap$128.4B
Dividend yield2.34%
Data as of 9:45am ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.41%
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)+6.49%
P/E ratio17.5
Price/Sales5.83
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.21+0.26%
BIIBBiogen-0.07-0.02%
ILMNIllumina Inc-0.28-0.16%
NBIXNeurocrine Bioscienc...-0.46-0.86%
Data as of 9:45am ET, 09/28/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts